- Home
- CING vs BGI Comparison
CING vs BGI Comparison
Compare CING & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CING
- BGI
- Stock Information
- Founded
- CING 2012
- BGI 1879
- Country
- CING United States
- BGI Canada
- Employees
- CING N/A
- BGI N/A
- Industry
- CING Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- CING Health Care
- BGI
- Exchange
- CING Nasdaq
- BGI Nasdaq
- Market Cap
- CING 17.3M
- BGI 17.8M
- IPO Year
- CING 2021
- BGI 2005
- Fundamental
- Price
- CING $5.50
- BGI $0.88
- Analyst Decision
- CING Strong Buy
- BGI
- Analyst Count
- CING 4
- BGI 0
- Target Price
- CING $30.67
- BGI N/A
- AVG Volume (30 Days)
- CING 104.9K
- BGI 87.4K
- Earning Date
- CING 08-12-2025
- BGI 07-25-2025
- Dividend Yield
- CING N/A
- BGI N/A
- EPS Growth
- CING N/A
- BGI N/A
- EPS
- CING N/A
- BGI N/A
- Revenue
- CING N/A
- BGI $124,446,731.00
- Revenue This Year
- CING N/A
- BGI N/A
- Revenue Next Year
- CING N/A
- BGI N/A
- P/E Ratio
- CING N/A
- BGI N/A
- Revenue Growth
- CING N/A
- BGI N/A
- 52 Week Low
- CING $1.80
- BGI $0.76
- 52 Week High
- CING $20.83
- BGI $2.95
- Technical
- Relative Strength Index (RSI)
- CING 66.64
- BGI 47.28
- Support Level
- CING $4.25
- BGI $0.82
- Resistance Level
- CING $6.01
- BGI $0.96
- Average True Range (ATR)
- CING 0.34
- BGI 0.08
- MACD
- CING 0.09
- BGI 0.00
- Stochastic Oscillator
- CING 71.02
- BGI 57.84
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.